xlif
-
Spine
NuVasive Announces First Commercial Cases Utilizing the Pulse Platform
Leading U.S. surgeons and hospitals complete first commercial cases with NuVasive’s integrated enabling technology platform for spine surgery SAN DIEGO, Sept.…
Read More » -
Spine
NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody
SAN DIEGO, Nov. 18, 2020 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
Results Validating the Versatility of NuVasive’s MaXcess® Retractor in Prone Single-Position XLIF® and Posterior Fixation Published in The European Spine Journal
SAN DIEGO, Feb. 13, 2020 /PRNewswire/ –NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Spine
NuVasive announces new evidence-based recommendation released from NICE (U.K.) for Lateral Interbody Fusion
SAN DIEGO, March 20, 2017 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery…
Read More » -
Spine
NuVasive to Resume XLIF Procedures in Japan in First Quarter 2017
SAN DIEGO, CA–(Marketwired – December 29, 2016) – NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine…
Read More » -
Spine
NuVasive (NUVA) to Acquire Brazilian Distributor Mega Surgical
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today…
Read More » -
Idata Research: Rapid Growth Of NuVasive’s XLIF® for the Treatment of Back Pain
According to new spinal implant reports by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market…
Read More »